Related references
Note: Only part of the references are listed.Overcoming Resistance of Glioblastoma to Conventional Cytotoxic Therapies by the Addition of PARP Inhibitors
Anthony J. Chalmers
Anti-Cancer Agents in Medicinal Chemistry (2012)
In Vitro Evaluation of Combined Temozolomide and Radiotherapy Using X Rays and High-Linear Energy Transfer Radiation for Glioblastoma
Lara Barazzuol et al.
RADIATION RESEARCH (2012)
Poly(ADP-Ribose) Polymerase Inhibition Synergizes with 5-Fluorodeoxyuridine but not 5-Fluorouracil in Ovarian Cancer Cells
Amelia M. Huehls et al.
CANCER RESEARCH (2011)
Phase I Study of PARP Inhibitor ABT-888 in Combination with Topotecan in Adults with Refractory Solid Tumors and Lymphomas
Shivaani Kummar et al.
CANCER RESEARCH (2011)
Poly(ADP-Ribose) Polymerase Inhibitor Induces Accelerated Senescence in Irradiated Breast Cancer Cells and Tumors
Elena V. Efimova et al.
CANCER RESEARCH (2010)
ABT-888 Confers Broad In vivo Activity in Combination with Temozolomide in Diverse Tumors
Joann P. Palma et al.
CLINICAL CANCER RESEARCH (2009)
CYTOTOXIC EFFECTS OF TEMOZOLOMIDE AND RADIATION ARE ADDITIVE- AND SCHEDULE-DEPENDENT
Anthony J. Chalmers et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies
Shivaani Kummar et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and O6-methylguanine-DNA methyltransferase activity
Terzah M. Horton et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Effective sensitization of temozolomide by ABT-888 is lost with development of temozolomide resistance in glioblastoma xenograft lines
Michelle J. Clarke et al.
MOLECULAR CANCER THERAPEUTICS (2009)
In vitro and in vivo radiosensitization induced by the DNA methylating agent temozolomide
Whoon Jong Kil et al.
CLINICAL CANCER RESEARCH (2008)
REPLICATION-DEPENDENT RADIOSENSITIZATION OF HUMAN GLIOMA CELLS BY INHIBITION OF POLY(ADP-RIBOSE) POLYMERASE: MECHANISMS AND THERAPEUTIC POTENTIAL
Fiona A. Dungey et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
A novel poly(ADP-ribose) polymerase inhibitor, ABT-888, radiosensitizes malignant human cell lines under hypoxia
Stanley K. Liu et al.
RADIOTHERAPY AND ONCOLOGY (2008)
Differential radiosensitizing potential of temozolomide in mgmt promoter methylated glioblastoma multiforme cell lines
Krista A. Van Nifterik et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
In vitro responsiveness of glioma cell lines to multimodality treatment with radiotherapy, temozolomide, and epidermal growth factor receptor inhibition with cetuximab
Stephanie E. Combs et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Inhibition of poly (ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models
Jeffrey M. Albert et al.
CLINICAL CANCER RESEARCH (2007)
ABT-888, an orallyactive poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models
Cherrie K. Donawho et al.
CLINICAL CANCER RESEARCH (2007)
Temozolomide-mediated radiation enhancement in glioblastoma: A report on underlying mechanisms
Arnab Chakravarti et al.
CLINICAL CANCER RESEARCH (2006)
Radiosensitization by the poly(ADP=ribose) polymerase inhibitor 4-amino-1,8-naphthalimide is specific of the S phase of the cell cycle and involves arrest of DNA syntheses
G Noël et al.
MOLECULAR CANCER THERAPEUTICS (2006)
O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells
M Hermisson et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Biologic basis for combining drugs with radiation
GD Wilson et al.
SEMINARS IN RADIATION ONCOLOGY (2006)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Poly(ADP-ribose) polymerase-1 is a positive regulator of the p53-mediated G1 arrest response following ionizing radiation
S Wieler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
PARP-1 modifies the effectiveness of p53-mediated DNA damage response
MT Valenzuela et al.
ONCOGENE (2002)
Survival of human glioma cells treated with various combination of temozolomide and X-rays
J van Rijn et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
Share Paper
